Furthermore, in advanced NSCLC harbouring an Epidermal Growth Factor Receptor (EGFR) mutation, it has been shown that smoking causes a decreased efficacy of EGFR tyrosine kinase inhibitors (TKIs) [10,11]. Here, EGFR is linked to non-small cell lung carcinoma.